PubRank

Mark O Goodarzi

Author PubWeight™ 91.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010 17.89
2 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010 6.66
3 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
4 Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013 2.92
5 Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 2010 2.45
6 A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 2011 2.09
7 Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 2008 1.78
8 A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012 1.72
9 CRTC3 links catecholamine signalling to energy balance. Nature 2010 1.55
10 Population structure of Hispanics in the United States: the multi-ethnic study of atherosclerosis. PLoS Genet 2012 1.53
11 A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet 2013 1.50
12 Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum Genet 2009 1.36
13 FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One 2011 1.16
14 Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care 2012 1.15
15 Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet 2013 1.13
16 Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab 2007 1.12
17 A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet 2011 1.10
18 The predictive role of blood glucose for mortality in subjects with cardiovascular disease. Am J Epidemiol 2005 1.09
19 Body adiposity index versus body mass index and other anthropometric traits as correlates of cardiometabolic risk factors. PLoS One 2013 1.09
20 Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab 2008 1.06
21 Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet 2012 1.01
22 Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril 2009 1.01
23 Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One 2011 1.00
24 Polycystic ovary syndrome: an ancient disorder? Fertil Steril 2010 0.99
25 Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA). Genet Epidemiol 2012 0.99
26 Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J Clin Endocrinol Metab 2011 0.98
27 Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing. Expert Rev Mol Diagn 2012 0.97
28 Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J 2005 0.93
29 Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity (Silver Spring) 2010 0.93
30 The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation. Atherosclerosis 2011 0.93
31 Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis study. Diabetes Care 2012 0.92
32 Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab 2015 0.92
33 Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol 2013 0.91
34 Genetic markers: progress and potential for cardiovascular disease. Circulation 2004 0.91
35 Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab 2009 0.90
36 A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause 2012 0.90
37 Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest 2015 0.90
38 Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril 2008 0.89
39 Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril 2006 0.89
40 Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens 2012 0.87
41 Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod 2012 0.87
42 Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril 2011 0.86
43 Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Fertil Steril 2006 0.86
44 No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes 2012 0.86
45 Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One 2012 0.84
46 Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids 2011 0.83
47 Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population. Diabetologia 2013 0.83
48 Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes. Mol Endocrinol 2014 0.80
49 Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab 2012 0.80
50 Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome. Fertil Steril 2009 0.79
51 Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. PLoS One 2011 0.78
52 Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol Hum Reprod 2012 0.78
53 Relationship of sex to diabetes risk in statin trials. Diabetes Care 2013 0.78
54 Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome. Eur J Endocrinol 2009 0.77
55 Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest 2016 0.76
56 Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention. Am J Med 2008 0.75
57 A Multinomial Ordinal Probit Model with Singular Value Decomposition Method for a Multinomial Trait. J Probab Stat 2012 0.75
58 Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis. Circ Cardiovasc Genet 2016 0.75
59 Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet 2017 0.75
60 Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 2016 0.75